HERTFORDSHIRE, England and PITTSBURGH, Oct. 19, 2018 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it has initiated the commercial launch of Hulio, a ...
Original Article: Mylan Launches Hulio (Biosimilar Adalimumab) in Markets Across Europe